Our last episode of Season 5 came out today! Check out this great conversation with Dr. Leah Salinsky on poly substance use and serotonin effects on addiction circuits! open.spotify.com/episode/0azy...

Have you listened to our latest episode ft Dimitri Mugianis, who has previously been on This American Life & Psychedelics Today? Dimitri’s story is incredible. From addiction to ibogaine healing to harm reduction to creating space at Cardea, you’ll wanna listen! open.spotify.com/episode/1TEI...

Apparently our podcast made it on the million podcast list of top 70 psychedelic podcasts! Coming at 39, we’re just happy to be on the same list as some of our own faves. www.millionpodcasts.com/psychedelic-...

We’ve got a very cool guest that will be our first episode of January 2026! He’s a musician, harm reductionist, psychedelic advocate, former heroin user, and so much more. He was featured on This American Life, among other media. Can you make a guess? 👀 Stay tuned for release on 1/5!!

Our last episode of 2025 is here! We chat with Andrew Ferns, a PhD candidate at University North Texas, about his journey as a chef, clandestine chemist and now scientist studying psychedelics and cognitive decline! Listen wherever you get pods or at this link⬇️ open.spotify.com/episode/1iLE...

New episode 🧠 This chat features Samantha Bumgardaner, MS, who is currently studying substance use disorders and psychedelics for her PhD at St. Louis University. They discuss everything from qualitative vs. quantitative research, therapeutic outcomes & much more! open.spotify.com/episode/61Yr...

New episode next week! Make sure to follow, like and subscribe to stay up to date with monthly episodes!!

It’s World Mental Health Day! It’s important that we engage with community members and legislators to better access for mental health treatments. We’re thrilled to share this convo with MI State Rep. Mike McFall + MI Psychedelic Society founder Julie Barron! open.spotify.com/episode/0rC7...

@deffinger.bsky.social and @melissaherman.bsky.social argue that, though many human psychedelic clinical trials are underway, preclinical studies remain our best bet to answer fundamental questions about the neurobiology of psychedelics. #neuroskyence www.thetransmitter.org/psychedelics...

Happy October! We’ve dropped a new episode discussing a paper on naturalistic psilocybin use & profile analysis related to cognition and addictive personality factors 🍄 Tune in wherever you get your pods! open.spotify.com/episode/4XNQ...

Are the Kids Alright? Cannabis edition is out now. 🍃 Our newest episode features Brooke Sanders talking about her work with adolescent cannabis use, epigenetics and zoom hacking while speaking at the UN. open.spotify.com/episode/3ARN...

🗞️ First article as #lastauthor published in Neuroscience of Consciousness @nconsc.bsky.social 🥳 🥳 🥳 academic.oup.com/nc/article/d... 🔍 In this study, we examine how #consciousness disruption translates into clinical manifestations in different #psychiatric disorders. 🧶⤵️

Come join us at the Per Ankh Church in Detroit today! We’re hosting an educational table at the Entheo Cup!!

BREAKING: Reunion Neuroscience Posts Strong Phase 2 Results for RE104 in Postpartum Depression Read our Deep Dive coverage, including a discussion with company management, now. psychedelicalpha.com/news/reunion...

We wanted to showcase that science intersects with everything, but make it fun. Our new segment “Causal Fridays” features casual conversations about topics that have a science behind them + link them with hot topics. First episode out now, subscribe to find out when the next one is!

We’ve now included a write up to reference on our blog: www.psychedelicbrainscience.com/post/researc...

Have you heard about the HALT Fentanyl Act? We made a little cheat sheet discussing what the act outlines in terms of research reform. For in depth information on each point follow our IG @psychedbrainsci

From Huxley to Heffter: Mark Geyer Reflects on a Life in Psychedelic Research psychedelicalpha.com/news/from-hu...

Heffter Research Institute co-founder Dr. Mark Geyer spoke with Dr. Alaina Jaster for our latest interview. Among the topics they discussed were so-called non-hallucinogenic psychedelics. Read more: psychedelicalpha.com/news/from-hu...

We are live with season 5 of the @psychedbrainsci.bsky.social podcast! Stream wherever you get your podcasts! open.spotify.com/episode/7526...

It’s wild how much change is possible in this life. From relearning to talk post-TBI, to full blown heroin addiction, to a life beyond anything I could have imagined. Im very fortunate to not only be alive, but to have been selected to speak at 2025 TEDxBoulder!

Psychedelic Brain Science is officially an LLC! To celebrate we’re launching Psychedelic Brain Science Consulting where a variety of services will be offered including workshops, one-on-one coaching, general consulting, independent analysis, and more! For details visit our website!

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2) Reporting by @jasteralaina.bsky.social. The entire Dispatch is now free to read. psychedelicalpha.com/news/dispatc...

Psychedelic Brain Science is officially an LLC!! Stay tuned for more on the next chapter 🍄🧠

The Your Brain On Science lineup for Fall of Season 5 has arrived! 🧠🧬 First episode drops August 5 🎙️ Make sure you subscribe wherever you get your pods or free on our website psychedelicbrainscience.com Plus we’ve got some exciting upcoming news related to new segments + more.

Check out my keynote & Day 1 dispatch of #GRCPsychedelics 🧠 via @psychedelicalpha.bsky.social psychedelicalpha.com/news/dispatc...

I love this: “The question isn't whether we can afford to invest in research. It's whether we can afford not to.” Keep that on repeat.

New report commissioned by Harvard reveals psychedelic training programs are in crisis. After MDMA's FDA rejection, it seems like the rush of new psychedelic trainees that was anticipated has stalled.

🌈🧠 The Trip Between Bedside and Bench 🌈🧠 Join us at #SfN2025 for a deep dive into cross-species research in psychedelic neuroscience! 🧬 Posters, 🎤 panels, 🔑 keynotes, 🍸 cocktails, and 🥟 tasty apps await. RSVP, explore speaker profiles, and help spread the word: 👉 hopkinspsychedelic.org/sfn2025

🍄🚨PSA Promo Alert 🚨 🍄 Tune in LIVE Friday 7/11 at 12 PM EST for the latest iteration of the Psychedelic State(s) of America Advocacy Spotlight Initiative, hosted by Dr. Alaina M. Jaster and featuring Dr. Jessica Nielson of Psychedelic Society Minnesota! Mushroom art created by Rita Ford!

In light of learning about this, we have taken down our episode featuring Sisko. While we believe the content of the episode was important, we do not support individuals that cause harm to others.

This week, Compass Pathways announced their initial endpoint data for COMP360. 🍄At 6 weeks post-dose, participants show reduced depressive symptoms and reduction in clinical depression scores. 🍄No increases in suicidality or other adverse events were seen from Phase 2 trials.

Fascinating to watch the variety of ways this new Compass news is being reported. It's inarguably significant news - the first Phase 3 data ever for psilocybin - but is it good or bad news? The first word that comes to mind is "modest" but it's also worth noting this is just the 1stpart of the trial

The DEA Judge has made his recommendation. Now, we continue to fight. Important - DOI and DOC are currently still legal. Until these compounds are officially listed on the registry, it’s business as usual.

Unfortunately, the DEA administrative judge has decided to recommend placement of DOI/DOC in Schedule I. This comes as a surprise given the stipulations of fact suggest no diversion, proven human use, or overdose related to DOI. For more: ssdp.org/blog/on-worl...

Its WORLD PSYCHEDELICS DAY (& the summer solstice) 🌞 Celebrate the longest day of the year by learning about psychedelics through our podcast & blog! Psychedelicbrainscience.com

If you liked the livestream and want to learn more about the specifics of the psychedelic legislation in Michigan, look no further! Co-authored by myself & @jackgorsline.bsky.social for Lucid News ⬇️⬇️ www.lucid.news/michigans-ps...

"It really does disappoint me that so many brilliant colleagues—whose genuine breakthroughs I’ve profited from for years—would be so quick to condemn this newer, stupider way that I and others like me can make money off your life’s work, through stealing."

🧪 Detailed data viz NYT article, out today, on the extent of funding cuts at the National Science Foundation. This "broken pie chart" is neat & new to me: Powerfully shows the slowdown in new NSF awards across areas. www.nytimes.com/interactive/...

Just lifted the paywall temporarily...

The website has been recently updated! Please subscribe on our contact page to stay informed of events, new pod episodes & more !! Psychedelicbrainscience.com

We are proud to announce our support & involvement in the Psychedelic Advocacy Spotlight spearheaded by @jackgorsline.Bsky.social & Psychedelic State(s) of America. The aim of the Initiative is to highlight amazing advocacy groups in all 50 states, Sovereign Nations + DC, Puerto Rico.

📚✨ ~500 Papers. ~30 Researchers & Experts. One Annotated Psychedelics Bibliography... Very excited to share the 2024 edition of Psychedelic Alpha's Interdisciplinary Annotated Psychedelic Research Bibliography, by @michaelhaichin.bsky.social. psychedelicalpha.com/news/the-int...

Topics we’d love to cover: 🧪 psychedelic science of any kind 💊 drugs that produce psychedelic like effects 🧑‍⚖️ policy work 👁️ ceremony/ritual use 🔬new/upcoming pubs 💰issues in funding / industry perspective Please comment here or reach out to us via email [email protected]!

Season 4 is over and we’re taking a little summer break while Dr. Jaster gets hitched! But don’t worry we’ll be back in August for season 5!!! 🤩 We’ve already got some great topics lined up and we’re excited to bring the 🔥 after a period of rest.

This report of interview with new NIH Director Jayanta Bhattacharya from @jocelynkaiser.bsky.social reveals a real $hit show... www.science.org/content/arti... 1/n

The final episode of Season 4 of Psychedelic Brain Science discusses a recent preprint that gets at the heart of reproducibility in science. This body of work titled "A multi-institutional investigation of psilocybin's effects on mouse behavior" can be found on BioRxiv!

Was on a podcast recently where I dive into the neuroscience of addiction, psychedelics, and healing—from both the science and my lived experience. Grateful for the chance to share my journey and the science behind what’s actually going on in the brain. Check it out: youtu.be/uNXrbEuturY

We have a new top streamed episode!! With 338 streams “Ambivalence in the psychedelic experience” featuring Abigail Calder of University of Fribourg takes the number 1 spot! Stream now wherever you get your pods or on our website!

I just attended a conference in the US. We had one speaker detained and two others turned away at the border.